Acute Myelocytic Leukemia  >>  Tomudex (raltitrexed)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tomudex (raltitrexed) / Pfizer, AstraZeneca
NCT00003528: Raltitrexed in Treating Children With Refractory Acute Leukemia

Completed
1
30
Europe
raltitrexed, D1694, ICI-D1694, TDX, Tomudex
National Cancer Institute (NCI)
Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia
06/02
 

Download Options